283.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$278.40
Aprire:
$279.22
Volume 24 ore:
2.80M
Relative Volume:
0.93
Capitalizzazione di mercato:
$152.46B
Reddito:
$34.13B
Utile/perdita netta:
$5.93B
Rapporto P/E:
25.87
EPS:
10.96
Flusso di cassa netto:
$10.92B
1 W Prestazione:
+4.28%
1M Prestazione:
-1.74%
6M Prestazione:
+0.24%
1 anno Prestazione:
-4.33%
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
283.54 | 146.20B | 34.13B | 5.93B | 10.92B | 10.96 |
![]()
LLY
Lilly Eli Co
|
722.57 | 642.06B | 49.00B | 11.11B | -1.27B | 12.29 |
![]()
JNJ
Johnson Johnson
|
153.58 | 367.19B | 89.33B | 21.81B | 18.57B | 8.99 |
![]()
ABBV
Abbvie Inc
|
185.62 | 322.44B | 57.37B | 4.20B | 15.39B | 2.35 |
![]()
NVS
Novartis Ag Adr
|
112.58 | 222.20B | 53.22B | 12.86B | 14.85B | 6.39 |
![]()
NVO
Novo Nordisk Adr
|
69.46 | 302.90B | 43.59B | 15.04B | 10.74B | 3.3766 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-20 | Ripresa | Guggenheim | Neutral |
2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
2024-12-10 | Ripresa | BofA Securities | Underperform |
2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
2024-11-14 | Iniziato | Citigroup | Neutral |
2024-10-17 | Iniziato | Bernstein | Outperform |
2024-10-14 | Downgrade | Truist | Buy → Hold |
2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-03-28 | Ripresa | Raymond James | Mkt Perform |
2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | Iniziato | Deutsche Bank | Hold |
2023-11-02 | Aggiornamento | Truist | Hold → Buy |
2023-10-20 | Ripresa | JP Morgan | Neutral |
2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
2023-10-11 | Ripresa | BofA Securities | Neutral |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2023-04-24 | Reiterato | Oppenheimer | Outperform |
2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-02-13 | Reiterato | Truist | Buy |
2022-11-18 | Iniziato | Credit Suisse | Underperform |
2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
2022-02-09 | Reiterato | Barclays | Equal Weight |
2022-02-09 | Reiterato | Jefferies | Buy |
2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
2022-02-09 | Reiterato | Oppenheimer | Outperform |
2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
2021-12-06 | Iniziato | Goldman | Buy |
2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-12-29 | Iniziato | Daiwa Securities | Buy |
2020-10-28 | Iniziato | UBS | Neutral |
2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-10-12 | Aggiornamento | Truist | Hold → Buy |
2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
2020-10-09 | Downgrade | Truist | Buy → Hold |
2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-04-15 | Ripresa | Guggenheim | Neutral |
2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-02-27 | Iniziato | Barclays | Equal Weight |
2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-12-24 | Iniziato | Raymond James | Mkt Perform |
2019-12-17 | Ripresa | Morgan Stanley | Overweight |
2019-11-12 | Iniziato | SunTrust | Buy |
2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-10-17 | Ripresa | BofA/Merrill | Neutral |
2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Korea approves Amgen's Imdeltar as first third-line treatment for small cell lung cancer - Chosunbiz
(AMGN) Long Term Investment Analysis - news.stocktradersdaily.com
Mackenzie Financial Corp Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
GTS Securities LLC Cuts Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
GF Fund Management CO. LTD. Invests $31.74 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight - GlobeNewswire Inc.
July 11th Options Now Available For Amgen (AMGN) - Nasdaq
Fairtree Asset Management Pty Ltd Invests $586,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Thoma Capital Management LLC Buys Shares of 2,621 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PKO Investment Management Joint Stock Co Makes New $5.68 Million Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Anchor Pointe Wealth Management LLC Invests $302,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Lighthouse Financial LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
IronOak Wealth LLC. Invests $313,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Alpha Wealth Funds LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is Amgen Stock a Buy? - AOL.com
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Trimmed by Toronto Dominion Bank - MarketBeat
Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference - Mondaq
Amgen Inc. (NASDAQ:AMGN) Shares Sold by JT Stratford LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Vise Technologies Inc. - MarketBeat
Novem Group Invests $328,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Forum Financial Management LP - MarketBeat
Regeneron Trial Team Talks $406.8M Win in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen - Law.com
Cancer Biologics Market Set to Witness High DemandRoche, Amgen - openPR.com
Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb - Yahoo Finance
1,282 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Kilter Group LLC - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Invests $193.34 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
LM Advisors LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Yoffe Investment Management LLC Makes New $366,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Public Employees Retirement System of Ohio Takes $59.90 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Great Valley Advisor Group Inc. Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
965 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Armis Advisers LLC - MarketBeat
United Advisor Group LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
4,827 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Pacific Point Advisors LLC - MarketBeat
Western Wealth Management LLC Has $1.43 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Parr Mcknight Wealth Management Group LLC Invests $3.75 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s SWOT analysis: biotech giant’s stock faces obesity market challenge By Investing.com - Investing.com India
Amgen’s SWOT analysis: biotech giant’s stock faces obesity market challenge - Investing.com
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
Twinbeech Capital LP Has $1.36 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zacks Research Has Strong Forecast for Amgen FY2025 Earnings - MarketBeat
Expert CFA Committee Flags Amgen as Potentially Undervalued Stock for Investors - Stock Titan
BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN) | AMGN Stock News - GuruFocus
BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN) - New Castle News
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Cypress Asset Management Inc. TX Acquires Shares of 3,829 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Leigh Baldwin & CO. LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Shufro Rose & Co. LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
95,000 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Polar Asset Management Partners Inc. - MarketBeat
Gould Capital LLC Cuts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen shareholders approve executive pay, ratify accountants By Investing.com - Investing.com India
Amgen shareholders approve executive pay, ratify accountants - Investing.com
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):